Netherlands
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -43.81 M
|
Dec. 31, 2023 | USD 662.53 | -0.67% |
|
Netherlands |
|
2 |
USD -3.98 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
3 |
USD -730.00 K
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
4 |
USD -99.32 K
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
5 |
USD -24.00 K
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
The Vaccines company in Netherlands with the highest Capital Expenditure is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD -43.81 M.
The Vaccines company in Netherlands with the lowest Capital Expenditure is NewAmsterdam Pharma Company N.V. (NasdaqGM: NAMS) at USD -24.00 K.
The top 10 Vaccines companies in Netherlands by Capital Expenditure are argenx SE, Merus N.V., LAVA Therapeutics N.V., Pharvaris N.V. and NewAmsterdam Pharma Company N.V..
The bottom 10 Vaccines companies in Netherlands by Capital Expenditure are NewAmsterdam Pharma Company N.V., Pharvaris N.V., LAVA Therapeutics N.V., Merus N.V. and argenx SE.